Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
TMEM2 expression is downregulated as bladder cancer invades the muscle layer.
Yoneyama MS, Yoneyama T, Tobisawa Y, Yamamoto H, Hatakeyama S, Yoneyama T, Hashimoto Y, Suzuki T, Ohyama C. Yoneyama MS, et al. Among authors: tobisawa y. Biochem Biophys Res Commun. 2022 Jul 12;613:1-6. doi: 10.1016/j.bbrc.2022.04.118. Epub 2022 Apr 29. Biochem Biophys Res Commun. 2022. PMID: 35525055 Free article.
Perilesional Targeted Biopsy Combined with MRI-TRUS Image Fusion-Guided Targeted Prostate Biopsy: An Analysis According to PI-RADS Scores.
Tomioka M, Seike K, Uno H, Asano N, Watanabe H, Tomioka-Inagawa R, Kawase M, Kato D, Takai M, Iinuma K, Tobisawa Y, Nakane K, Tsuchiya K, Ito T, Koie T. Tomioka M, et al. Among authors: tobisawa y. Diagnostics (Basel). 2023 Aug 7;13(15):2608. doi: 10.3390/diagnostics13152608. Diagnostics (Basel). 2023. PMID: 37568971 Free PMC article.
Blood group antigen-targeting peptide suppresses anti-blood group antibody binding to antigen in renal glomerular capillaries after ABO-incompatible blood reperfusion.
Yoneyama T, Hatakeyama S, Tobisawa Y, Yamamoto H, Imanishi K, Okamoto T, Tokui N, Sugiyama N, Suzuki Y, Kudo S, Yoneyama T, Hashimoto Y, Koie T, Kamimura N, Fukuda MN, Ohyama C. Yoneyama T, et al. Among authors: tobisawa y. Transplantation. 2013 Feb 15;95(3):418-25. doi: 10.1097/TP.0b013e3182795b9c. Transplantation. 2013. PMID: 23274971
Tumor targeting by a carbohydrate ligand-mimicking peptide.
Hatakeyama S, Shibata TK, Tobisawa Y, Ohyama C, Sugihara K, Fukuda MN. Hatakeyama S, et al. Among authors: tobisawa y. Methods Mol Biol. 2013;1022:369-86. doi: 10.1007/978-1-62703-465-4_28. Methods Mol Biol. 2013. PMID: 23765676
Serum N-glycan profiling predicts prognosis in patients undergoing hemodialysis.
Hatakeyama S, Amano M, Tobisawa Y, Yoneyama T, Tsushima M, Hirose K, Yoneyama T, Hashimoto Y, Koie T, Saitoh H, Yamaya K, Funyu T, Nishimura S, Ohyama C. Hatakeyama S, et al. Among authors: tobisawa y. ScientificWorldJournal. 2013 Dec 23;2013:268407. doi: 10.1155/2013/268407. eCollection 2013. ScientificWorldJournal. 2013. PMID: 24453820 Free PMC article. Clinical Trial.
Outcome comparison of ABO-incompatible kidney transplantation with low-dose rituximab and ABO-compatible kidney transplantation: a single-center experience.
Hatakeyama S, Fujita T, Murakami R, Suzuki Y, Sugiyama N, Yamamoto H, Okamoto A, Imai A, Tobisawa Y, Yoneyama T, Mori K, Yoneyama T, Hashimoto Y, Koie T, Narumi S, Ohyama C. Hatakeyama S, et al. Among authors: tobisawa y. Transplant Proc. 2014;46(2):445-8. doi: 10.1016/j.transproceed.2013.09.036. Transplant Proc. 2014. PMID: 24655984
121 results